CuraScientific (CSTF) Stock Statistics & Valuation Metrics
Total Valuation
CuraScientific has a market cap or net worth of $3,773.00. The enterprise value is $3.01T.
- Market Cap
- $3,773.00
- Enterprise Value
- $3.01T
Share Statistics
CuraScientific has 3,773,448,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 3,773,448,000
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
CuraScientific’s return on equity (ROE) is 0.08 and return on invested capital (ROIC) is 3.57%.
- Return on Equity (ROE)
- 0.08
- Return on Assets (ROA)
- -3.39
- Return on Invested Capital (ROIC)
- 3.57%
- Return on Capital Employed (ROCE)
- 0.03
- Revenue Per Employee
- 17.22K
- Profits Per Employee
- -2.63M
- Employee Count
- 2
- Asset Turnover
- 0.02
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of CuraScientific is -0.00. CuraScientific’s PEG ratio is -0.00.
- PE Ratio
- -0.00
- PS Ratio
- 10.96
- PB Ratio
- -0.00
- Price to FCF
- -1.40
- Price to Operating Cash Flow
- -0.00
- PEG Ratio
- -0.00
Income Statement
In the last 12 months, CuraScientific had revenue of 34.43K and earned -5.27M in profits. Earnings per share was -1.11.
- Revenue
- 34.43K
- Gross Profit
- -1.14M
- Operating Income
- -2.38M
- Pretax Income
- -5.27M
- Net Income
- -5.27M
- EBITDA
- -4.03M
- Earnings Per Share (EPS)
- -1.11
Cash Flow
In the last 12 months, operating cash flow was -304.30K and capital expenditures -97,686, giving a free cash flow of -401.99K billion.
- Operating Cash Flow
- -304.30K
- Free Cash Flow
- -401.99K
- Free Cash Flow per Share
- -0.06
Dividends & Yields
CuraScientific pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -71.19%
- Earnings Yield
- -1114826.08%
Stock Price Statistics
- Beta
- 142.21
- 52-Week Price Change
- -99.82%
- 50-Day Moving Average
- ―
- 200-Day Moving Average
- ―
- Relative Strength Index (RSI)
- ―
- Average Volume (3m)
- ―
Financial Position
CuraScientific as a current ratio of 0.00, with Debt / Equity ratio of -3.79%
- Current Ratio
- 0.00
- Quick Ratio
- 0.00
- Debt to Market Cap
- 0.06
- Net Debt to EBITDA
- -0.77
- Interest Coverage Ratio
- -1.95
Taxes
In the past 12 months, CuraScientific has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
CuraScientific EV to EBITDA ratio is -0.75, with an EV/FCF ratio of -11.22.
- EV to Sales
- 87.55
- EV to EBITDA
- -0.75
- EV to Free Cash Flow
- -11.22
- EV to Operating Cash Flow
- -11.88
Balance Sheet
CuraScientific has $40.91K in cash and marketable securities with $733.93K in debt, giving a net cash position of -$693.02K billion.
- Cash & Marketable Securities
- $40.91K
- Total Debt
- $733.93K
- Net Cash
- -$693.02K
- Net Cash Per Share
- $0.00
- Tangible Book Value Per Share
- -$0.03
Margins
Gross margin is -3298.12%, with operating margin of -6910.85%, and net profit margin of -15299.16%.
- Gross Margin
- -3298.12%
- Operating Margin
- -6910.85%
- Pretax Margin
- -15299.16%
- Net Profit Margin
- -15299.16%
- EBITDA Margin
- -11712.11%
- EBIT Margin
- -11759.33%
Analyst Forecast
The average price target for CuraScientific is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- 0
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- ―